Treatment with unmodified HCT negligibly induced the tumor infiltration of CD4+ and CD8+ T cells, whereas HCT-mono-mIL12 treatment triggered tumor infiltration of those cells (Figure 5B). The gene discussed is CD8A; the disease is neoplasm.